Evolution of Phosphodiesterase-5 Inhibitors

被引:5
|
作者
Moon, Du Geon [1 ]
机构
[1] Korea Univ, Guro Hosp, Dept Urol, 148 Gurodong Ro, Seoul 08308, South Korea
来源
WORLD JOURNAL OF MENS HEALTH | 2015年 / 33卷 / 03期
关键词
ERECTILE DYSFUNCTION; TADALAFIL; SAFETY; MEN;
D O I
10.5534/wjmh.2015.33.3.123
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:123 / +
页数:2
相关论文
共 50 条
  • [1] Pharmacology of phosphodiesterase-5 inhibitors
    Corbin, JD
    Francis, SH
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (06) : 453 - 459
  • [2] Phosphodiesterase-5 inhibitors and migraine
    Evans, RW
    Kruuse, C
    [J]. HEADACHE, 2004, 44 (09): : 925 - 926
  • [3] Cardiac Uses of Phosphodiesterase-5 Inhibitors
    Schwartz, Bryan G.
    Levine, Laurence A.
    Comstock, Gary
    Stecher, Vera J.
    Kloner, Robert A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (01) : 9 - 15
  • [4] Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
    Tegos, George
    [J]. FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [5] Phosphodiesterase-5 inhibitors and their hemodynamic effects
    L. Michael Prisant
    [J]. Current Hypertension Reports, 2006, 8 : 345 - 351
  • [6] ADMET considerations for phosphodiesterase-5 inhibitors
    Rezvanfar, Mohammad Amin
    Rahimi, Hamid Reza
    Abdollahi, Mohammad
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (10) : 1231 - 1245
  • [7] Phosphodiesterase-5 Inhibitors: Future Perspectives
    Konstantinos, Giannitsas
    Petros, Perimenis
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (30) : 3540 - 3551
  • [8] PHOSPHODIESTERASE-5 INHIBITORS IN MEN WITH HIV
    Dinsmore, W.
    Mccarty, E.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 87 - 87
  • [9] Phosphodiesterase-5 inhibitors and their hemodynamic effects
    Prisant, L. Michael
    [J]. CURRENT HYPERTENSION REPORTS, 2006, 8 (04) : 345 - 351
  • [10] Phosphodiesterase-5 inhibitors for male erectile dysfunction
    Sui, ZH
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1373 - 1388